Repligen reports Q3 adjusted EPS 43c, consensus 33c
PremiumThe FlyRepligen reports Q3 adjusted EPS 43c, consensus 33c
8d ago
Is RGEN a Buy, Before Earnings?
Premium
Pre-Earnings
Is RGEN a Buy, Before Earnings?
24d ago
Repligen opens RTIC at Waltham headquarters
Premium
The Fly
Repligen opens RTIC at Waltham headquarters
2M ago
Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls
PremiumThe FlyIllumina upgraded, Fiserv initiated: Wall Street’s top analyst calls
3M ago
Wells Fargo starts tools and diagnostics group with positive bias
Premium
The Fly
Wells Fargo starts tools and diagnostics group with positive bias
3M ago
Repligen initiated with an Overweight at Wells Fargo
Premium
The Fly
Repligen initiated with an Overweight at Wells Fargo
3M ago
Repligen approached Maravai with takeover offer, Reuters reports
PremiumThe FlyRepligen approached Maravai with takeover offer, Reuters reports
3M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
Repligen sees 2024 adjusted EPS $1.42-$1.49, consensus $1.45
Premium
The Fly
Repligen sees 2024 adjusted EPS $1.42-$1.49, consensus $1.45
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100